|
|
|
09192
|
|
|
P.I.:
|
Auayporn Nademanee, MD
|
(Industrial)
|
|
Title:
|
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of SGN-35 (brentuximab vedoltin) and best supportive care (BSC) versus placebo and BSC in the treatment of patients at high risk of residual Hodgkin Lymphoma (HL) following autologous stem cell transplant (ASCT)
|
| | |
|
|
09072
|
|
|
P.I.:
|
Auayporn Nademanee, MD
|
(Industrial)
|
|
Title:
|
Long-Term Observational Follow-Up Study of a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Plus Placebo to Mobilize and Collect 6 x 106 CD34 + Cells/kg in Multiple Myeloma Patients for Autologous Transplantation
|
|
|
09071
|
|
|
P.I.:
|
Auayporn Nademanee, MD
|
(Industrial)
|
|
Title:
|
Long-term Observational Follow-up Study of a Multicenter, Randomized, Double-blind, Placebo-controlled, Comparative Trial of AMD3100 (240ug/kg)plus G-CSF (10 ug/kg) Versus G-CSF (10 ug/kg) Plus Placebo to Mobilize and Collect >= 5 x 10^6 CD34+ Cells/kg in Non-Hodkin's Lymphoma Patients for Autologous Transplantation
|
| | |
|
|
09041
|
|
|
P.I.:
|
Auayporn Nademanee, MD
|
(Cooperative Group)
|
|
Title:
|
BMT CTN 0701: Phase II Trial of Non-Myeloblative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response
|
| | |
|
|
05149
|
|
|
P.I.:
|
Auayporn Nademanee, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for B–Cell Non–Hodgkin Lymphoma Using Zevalin®, Fludarabine and Melphalan
|
| | |
|